Literature DB >> 921343

Cellular immunity in systemic lupus erythematosus as evidenced in vitro by leucocyte migration inhibition tests.

M Okubo, Y Nagura, D Pompa, G Treser, K Lange.   

Abstract

A leucocyte migration inhibition test was performed on 26 patients with systemic lupus erythematosus (SLE) and on 35 control subjects using three different antigens, fetal calf thymus DNA, baker's yeast RNA, and calf thymus extractable nuclear antigen (ENA). Leucocyte migration was inhibited by DNA in 17 out of 26 SLE patients (65-3%), and in only 2 of the 35 controls (5-7%). When RNA or ENA was added none of the patients or controls showed inhibition. In SLE patients migration inhibition by DNA was significantly correlated with the presence of proteinuria and/or granular casts in urinary sediment. When the migration inhibition test was positive, immunofluorescence verified active histology of the glomeruli obtained by a percutaneous renal biopsy.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 921343      PMCID: PMC1000135          DOI: 10.1136/ard.36.5.433

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  36 in total

1.  SKIN TEST FOR THE DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS.

Authors:  R O ORES; K LANGE
Journal:  Am J Med Sci       Date:  1964-11       Impact factor: 2.378

2.  Antibodies to enatured deoxyribonucleic acid in lupus erythematosus serum. II. Characterization of antibodies in several sera.

Authors:  D STOLLAR; L LEVINE; J MARMUR
Journal:  Biochim Biophys Acta       Date:  1962-07-09

3.  A simple fractionation method for preparation of fluorescein-labeled gamma globulin.

Authors:  J L RIGGS; P C LOH; W C EVELAND
Journal:  Proc Soc Exp Biol Med       Date:  1960-12

4.  The L. E. cell and the L. E. serum factors.

Authors:  H R HOLMAN; H R DEICHER; H G KUNKEL
Journal:  Bull N Y Acad Med       Date:  1959-07

5.  The significance of serum complement levels for the diagnosis and prognosis of acute and subacute glomerulonephritis and lupus erythematosus disseminatus.

Authors:  K LANGE; E WASSERMAN; L B SLOBODY
Journal:  Ann Intern Med       Date:  1960-10       Impact factor: 25.391

6.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

7.  Leucocyte-migration test in seronegative S.L.E.

Authors:  P Galanaud; J Dormont; J Crosnier; J P Mery
Journal:  Lancet       Date:  1971-10-23       Impact factor: 79.321

8.  Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA).

Authors:  G C Sharp; W S Irvin; E M Tan; R G Gould; H R Holman
Journal:  Am J Med       Date:  1972-02       Impact factor: 4.965

9.  [The leukocyte migration test in the presence of DNA during disseminated lupus erythematosus].

Authors:  R Moulias; J M Goust; P Reinert; A Devillechabrolle; C N Muller Berat; C Hereman; P Godeau
Journal:  Nouv Presse Med       Date:  1972-05-20

10.  The precipitin reaction between DNA and a serum factor in systemic lupus erythematosus.

Authors:  H R DEICHER; H R HOLMAN; H G KUNKEL
Journal:  J Exp Med       Date:  1959-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.